Early Termination of Clinical Trials for Futility - Considerations for a Data and Safety Monitoring Board
Overview
Authors
Affiliations
Early Termination of Clinical Trials for FutilityClinical trials may be stopped for futility if there is little or no chance of demonstrating the hoped-for effect. Reasons include evidence of no treatment effect, substantial missing data that would unacceptably undermine trial conclusions, or event rates too low to support meaningful comparisons. This review examines issues faced by DSMBs in such settings.
Lala S, Jha N Trials. 2025; 26(1):31.
PMID: 39881374 PMC: 11780961. DOI: 10.1186/s13063-024-08661-1.
Inside the Mind of the DMC: A Review of Principles and Issues with Case Studies.
Ge L, Hamasaki T, Evans S Ther Innov Regul Sci. 2024; 59(2):234-244.
PMID: 39688768 DOI: 10.1007/s43441-024-00720-8.
Armeni K, Chambers L, Peachey A, Berk J, Langdon K, Peterson L BMJ Open. 2024; 14(11):e085888.
PMID: 39521460 PMC: 11551980. DOI: 10.1136/bmjopen-2024-085888.
Werlenius K, Kinhult S, Solheim T, Magelssen H, Lofgren D, Mudaisi M JAMA Netw Open. 2023; 6(3):e234149.
PMID: 37000452 PMC: 10066460. DOI: 10.1001/jamanetworkopen.2023.4149.